29
was determined by production of cytokines TNF-α, IFN-γ, and IL-10 using specific ELISA kits.
30
DPV576 treatment of CD4+ T cells that were activated with anti CD3/CD28, resulted in increased 31 expression of TRPV1 channel but had no effect on TRPV4. This was accompanied by increased 32 secretion of IFN-γ and reduced expression of TRPV1 in capsaicin activated CD4+ T cells. In addition, 
Introduction

114
Statistical analysis for experiments was performed using GraphPad Prism (GraphPad Inc., San
115
Diego, CA, USA). T-test was used for analysis. A P-value of < 0.05 was considered statistically 116 significant.
117
Results
118
DPV576 modulates the expression of TRPV1 on CD4+ T cells.
119
We determined the expression of TRPV1 channels on CD4+ T cells with and without DPV576 
149
Red: DPV576 exposed lymphocytes; Green: isotype. 
162
Data is mean +/-S.E. of three experiments. * p<0.05. 
164
To investigate the effect of DPV576 on the TRPV1 agonist capsaicin-induced TRPV1 activity, we 
190
Data is mean +/-S.E. of three experiments. * p<0.05 
236
Conclusions
237
Short term exposure to DPV576 inhibits the activity of TRPV1 channels in CD4+ T lymphocytes,
238
which may suggest its possible beneficial use for pain management. To our knowledge, this study is 239 the first investigation into these potential therapeutic properties of nanoparticles.
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